NAMPT and Parkinson disease: In a study by Parsons et al. [93], post-mortem examinations of PD patients were conducted to assess levels of NAMPT and nicotinamide mononucleotide adenylyl transferase (NMNAT) in the caudate nucleus, in relation to the amount of monomeric alpha-synuclein.